Back to search results

Initial Feasibility Study to Treat Borderline Resectable Pancreatic Cancer With a Planar LDR Source

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Pancreatic Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Tampa General Hospital, Tampa, Florida, United States

    Contact: Study coordinator (Raegen Einsmann) · reinsmann@usf.edu · 813-974-7247
    Contact: Principal Investigator (Timothy Nywening, MD)

  • Rush University Cancer Center, Chicago, Illinois, United States

  • Advocate Christ Medical Center, Oak Lawn, Illinois, United States

    Contact: Study coordinator (Colleen Valenti, OCN) · colleen.valenti@advocatehealth.com · 708-684-4694
    Contact: Principal Investigator (Paul Crossan, MD)
    Marc Mesleh, MD (Sub-investigator)

  • University Medical Center LSU, New Orleans, Louisiana, United States

  • Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States

  • Virginia Commonwealth University Massey Cancer Center, Richmond, Virginia, United States

Study leads

  • Joshua Meyer, MD

    Principal Investigator

    Fox Chase Cancer Center

View source on ClinicalTrials.gov(opens in a new tab)Contact study team (email)